Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 888
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +13.3%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 451–500 of 3,853 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07092566	R.E.C.K vs Exparel in Robotic Nephrectomy	recruiting	Phase 3	170	Wake Forest University Health SciencesOTHER	1	Jul 13, 2026	clinicaltrials
NCT07697417	Multimodal Prediction of Postoperative Prognosis After Partial Nephrectomy for Endophytic Renal Cell Carcinoma(PN-ProMM)	active not recruiting	—	406	Tianjin Medical University Second HospitalOTHER	1	Jul 13, 2026